mannitol has been researched along with carbamazepine in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (12.50) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 8 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Danelian, E; Hämäläinen, MD; Hansson, A; Karlén, A; Karlsson, R; Lennernäs, H; Löfâs, S; Winiwarter, S | 1 |
| Hwang, KK; Mandagere, AK; Thompson, TN | 1 |
| Faassen, F; Spanings, H; Vogel, G; Vromans, H | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Barber, S; Dew, TP; Farrell, TL; Poquet, L; Williamson, G | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bartolome, V; Mendizabal, S; Simon, J; Zamora, I | 1 |
| Bartolome, V; Martinez-sanchez, F; Simon, J; Zamora, I | 1 |
| Otto, C; Richter, WO | 1 |
| Vivancos Mora, J | 1 |
| Betz, G; Eberle, VA; Flicker, F | 1 |
| Kraciuk, R; Sznitowska, M | 1 |
2 review(s) available for mannitol and carbamazepine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Treatment of neurological complications: cerebral edema and epileptic seizures].
Topics: Adrenal Cortex Hormones; Anticonvulsants; Brain Edema; Brain Ischemia; Carbamazepine; Diuretics, Osmotic; Epilepsy; Lorazepam; Mannitol | 1995 |
14 other study(ies) available for mannitol and carbamazepine
| Article | Year |
|---|---|
SPR biosensor studies of the direct interaction between 27 drugs and a liposome surface: correlation with fraction absorbed in humans.
Topics: Humans; Intestinal Absorption; Liposomes; Pharmaceutical Preparations; Pharmacokinetics; Predictive Value of Tests; Surface Plasmon Resonance | 2000 |
Graphical model for estimating oral bioavailability of drugs in humans and other species from their Caco-2 permeability and in vitro liver enzyme metabolic stability rates.
Topics: Administration, Oral; Animals; Biological Availability; Caco-2 Cells; Dogs; Guinea Pigs; Humans; In Vitro Techniques; Inactivation, Metabolic; Liver; Microsomes, Liver; Models, Biological; Permeability; Pharmacokinetics; Rats; Species Specificity | 2002 |
Caco-2 permeability, P-glycoprotein transport ratios and brain penetration of heterocyclic drugs.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain; Caco-2 Cells; Cell Membrane Permeability; Heterocyclic Compounds; Humans; Protein Transport | 2003 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Predicting phenolic acid absorption in Caco-2 cells: a theoretical permeability model and mechanistic study.
Topics: Artificial Intelligence; Caco-2 Cells; Cell Membrane Permeability; Cinnamates; Enterocytes; Humans; Hydrophobic and Hydrophilic Interactions; Intestinal Absorption; Kinetics; Models, Biological; Molecular Conformation; Osmolar Concentration; Phenols | 2012 |
Evaluation of carbamazepine and clofibrate antidiuretic effect by mannitol osmolar clearance.
Topics: Carbamazepine; Child; Clofibrate; Diabetes Insipidus; Diuresis; Drug Evaluation; Drug Therapy, Combination; Humans; Kidney Concentrating Ability; Male; Mannitol; Osmolar Concentration; Vasopressins | 1979 |
Mannitol osmolar clearance in diabetes insipidus of children.
Topics: Carbamazepine; Child; Child, Preschool; Clofibrate; Diabetes Insipidus; Diuresis; Evaluation Studies as Topic; Humans; Infant; Kidney; Kidney Concentrating Ability; Kidney Function Tests; Mannitol; Osmolar Concentration; Vasopressins | 1978 |
Syndrome of inappropriate antidiuretic hormone secretion induced by different drugs.
Topics: Adult; Antineoplastic Agents; Carbamazepine; Female; Fluid Therapy; Humans; Inappropriate ADH Syndrome; Mannitol | 1994 |
Variability in commercial carbamazepine samples--impact on drug release.
Topics: Anticonvulsants; Calorimetry, Differential Scanning; Carbamazepine; Cellulose; Crystallization; Excipients; Mannitol; Microscopy, Electron, Scanning; Particle Size; Solubility; Tablets; X-Ray Diffraction | 2011 |
Effect of different excipients on the physical characteristics of granules and tablets with carbamazepine prepared with polyethylene glycol 6000 by fluidized hot-melt granulation (FHMG).
Topics: Anticonvulsants; Calcium Phosphates; Carbamazepine; Cellulose; Chemistry, Pharmaceutical; Drug Carriers; Drug Compounding; Excipients; Hot Temperature; Kinetics; Lactose; Mannitol; Particle Size; Polyethylene Glycols; Powders; Solubility; Starch; Tablets; Technology, Pharmaceutical | 2011 |